Author:
Backman Janne T.,Karjalainen Marjo J.,Neuvonen Mikko,Laitila Jouko,Neuvonen Pertti J.
Subject
Pharmacology (medical),Pharmacology
Reference37 articles.
1. 2 Kick A, Bertoli R, Moschovitis G, Caduff Janosa P, Cerny A. [Extreme sinus bradycardia (30/min) with acute right heart failure under tizanidine (Sirdalud). Possible pharmacological interaction with rofecoxib (Vioxx)]. Med Klin (Munich) 2005; 100: 213-6.
2. 3 Topol EJ. Failing the public health-rofecoxib, Merck, and the FDA. N Engl J Med 2004; 351: 1707-9.
3. 4 VIOXX (Rofecoxib Tablets and Oral Suspension). Whitehouse Station, NJ: Merck, Inc. 2002. Available from URL:http://www.fda.gov/medwatch/SAFETY/2003/03May_PI/vioxx_pi.pdf Last accessed2005 .
4. The Disposition and Metabolism of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Human Subjects
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献